Ny hövding till Roche

Roche har utsett en efterträdare till nypensionerade Curt Collin på posten som chef för External Affairs.

KI-forskare får femårig forskningsprofessur

Torsten och Ragnar Söderbergs stiftelser ger Christer Betsholtz möjlighet att i fem år heltidsforska om tillväxtfaktorers roll i cancer

Carl Borrebaeck blir vicerektor i Lund

Universitetsledningen i Lund förstärks med tre nya vicerektorer. Dessutom blir det en extra satsning på ledarskap, lärarskap och innovationer.

Roche sänker budet på Genentech

I juli ifjol var budet 89 dollar per aktie. Då sa Genentechs styrelse nej tack. Nu meddelar läkemedelsjätten att man sänker budet och vänder sig direkt till småägarna.

Lunds nya rektor har tillträtt

Nu är han på plats. Vinnovas förre generaldirektör tar över rodret vid Lunds universitet.

Hårt tryck på Läkemedelsverket

Alltför många vill ansöka om Sverige som referensland i den decentraliserade processen för att godkänna läkemedel. Idag införs nya rutiner för att hantera situationen.

Faster sales but less profits for Probi

The probiotic company increases its turnover, and the net results are twice as large as last year.

Go ahead for leg wound study

Tripep starts a phase II-study of their wound healing joint venture project.

Success fee to Bioinvent and partner

The cancer collaboration started last year. After successful technology transfer the two partner companies now receives 5 million euro from pharma giant Roche.

Lundbeck divests companies

The company sells all shares in one listed company plus divests four small private equity funds, for a three-figured million sum.

New CEO to Promedvi

Sigrun Axelsson has taken on the leadership of the Lund-based medtech company.

Metabolic pro heads prefect post

The dean of the Department of Biomedicine at the Sahlgrenska Academy has appointed a new assistant prefect.

Biotech goes white and bright

White biotech could become Denmark's next blossoming business area.

Oasmia gets a confirmation

FDA has granted Oasmia an expedited review status for Paclical Vet.

Dako appoints new CEO

The Danish cancer therapeutic company Dako has appointed a new CEO after Patrik Dahlén.

Woman deficit in Swedish research

The IP firm Awapatent will soon launch its Innovation Barometer 2009. This year Awapatent reveals that the statistics is even worse, compared to last year.

Harmony prevents dementia

People who are active, outgoing and relaxed may be less likely to develop dementia, according to a new study from Karolinska Institutet.

New NO product reduces diabetic pain

The Swedish medtech company Nolabs has announced that it has achieved an important milestone in the development of a new line of products.

Positive combined cancer therapy

Topotarget announces positive data with new treatment against colorectal cancer.

Dupont gets new business manager

The Swedish API manufacturer Dupont Chemoswed has appointed a new business development manager.

Abbott expands by acquisition

An acquisition gives Abbott a leadership position in another large and growing medical device segment.

Pharma is a safe market

Pharma is the best industry to invest in. That states leaders from risk capital companies, interviewed by the Economist Intelligence Unit.

LEO Pharma - International Clinical Trial Manager

Vitrolife wants to acquire Medicult

The Swedish company Vitrolife intends to make en exchange offer to the shareholders of the Danish company Medicult to acquire all outstanding shares in the company.